Ophthotech rebrands as Iveric as focus turns to retinal gene therapies

Ophthotech Corp. (NASDAQ:OPHT) changed its name and ticker to Iveric

Read the full 107 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE